Kyoto University Innovation Capital

What Kyoto University Innovation Capital does

Kyoto University Innovation Capital Co., Ltd. (京都大学イノベーションキャピタル株式会社, KYOTO-iCAP) is a venture capital firm established in December 2014 as a 100% wholly-owned subsidiary of National Universities Corporation Kyoto University. The firm invests in and provides operational support to companies commercializing research, technologies, and intellectual property generated by Kyoto University researchers. Its portfolio spans more than 36 companies across life sciences, biotechnology, medical devices, quantum computing, energy, materials, and AI-applied domains. KYOTO-iCAP is headquartered in Kyoto University's International Science Innovation Building, with a Singapore representative office opened in April 2024 to support ASEAN expansion.

The firm's core offering is equity investment via its KYOTO-iCAP Fund No. 2 and related vehicles, complemented by two startup creation programs: ECC-iCAP (Entrepreneur Candidate Club), which connects Kyoto University researchers with business professionals, and EIR-iCAP (Entrepreneur in Residence), which embeds aspiring founders within the firm to develop investable companies from academic IP. Notable portfolio companies include aceRNA Technologies (iPS cell RNA technology), Shinobi Therapeutics (iPS-based cancer immunotherapy), Yaqumo (neutral-atom quantum computing), Rhinoflux (low-CO2 power generation), Physiologas Technologies (home hemodialysis), and Restore Vision (optogenetics gene therapy).

Revenue is generated through capital gains on portfolio exits (IPOs and M&A), management fees on venture funds, and carried interest, though no revenue figures are publicly disclosed. Deal flow is sourced exclusively through Kyoto University relationships and the firm's in-house creation programs rather than inbound channels. The investment team of approximately 17 professionals includes former pharma R&D leaders (Kyowa Hakko Kirin, Takeda, Astellas, Chugai), banking executives (SMBC, MUFG), consultants (Arthur D. Little, Deloitte, PwC), and seconded corporate staff, enabling deep scientific evaluation and hands-on portfolio support.

Name

Kyoto University Innovation Capital

Legal name

Kyoto University Innovation Capital Co., Ltd.

Website

https://kyoto-unicap.co.jp

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Kyoto University Innovation Capital is the 100% subsidiary venture capital arm of Kyoto University, investing in and supporting startups that commercialize Kyoto University research across life sciences, deep tech, and quantum computing via dedicated funds and startup creation programs.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Other Financial Investment Activities (5239), All Other Financial Investment Activities (52399)

SIC

Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Accelerators & Incubators (Investor-Operated) (FSANAAAM)

akta.pro secondary industries

Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH), Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG)

Keywords

• Venture capital services
• University startup funding
• Deep tech investment
• Startup creation programs
• Equity investment management

Headquarters

HQ city

Kyoto

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Revenue model

1. Investment Returns and Fund Management: KYOTO-iCAP generates returns through capital gains on equity investments in portfolio companies (IPOs, M&A exits), management fees on its venture capital funds (KYOTO-iCAP Fund No. 2), and carried interest from fund operations. As a 100% subsidiary of Kyoto University, it operates as a university-launched VC with a mission to commercialize university research.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Kyoto University Innovation Capital (KYOTO-iCAP) provides equity investment and hands-on operational support to startups that commercialize research outputs from Kyoto University researchers, deploying capital through funds such as KYOTO-iCAP Fund No. 2. The firm also operates startup creation programs — ECC-iCAP (Entrepreneur Candidate Club) connecting researchers with business professionals, and EIR-iCAP (Entrepreneur in Residence) placing aspiring founders to develop ventures from university research seeds.

Product overview

Kyoto University Innovation Capital (Kyoto-iCAP) is a venture capital firm established in December 2014 as a 100% subsidiary of Kyoto University. The company operates a unified platform combining investment services with startup creation programs. The core investment offering is complemented by two key programs: ECC-iCAP (Entrepreneur Candidate Club), which connects researchers with business professionals for commercialization, and EIR-iCAP (Entrepreneur in Residence), which provides a structured pathway for aspiring entrepreneurs to develop startups from Kyoto University research.

Differentiator

Problem solved

Functional benefit

Products and services

• Equity Investment Services Direct equity investment services for startups commercializing Kyoto University research outputs, deployed through venture capital funds including KYOTO-iCAP Fund No. 2, with milestone-based funding and post-investment operational support covering business planning, fundraising, licensing, and governance.
• ECC-iCAP (Entrepreneur Candidate Club) A platform and community program connecting Kyoto University researchers with engineers and business people to commercialize research seeds, providing matching services, pitch events, networking meetups, and mentorship for aspiring entrepreneurs seeking to found university-originated ventures.
• EIR-iCAP (Entrepreneur in Residence) Entrepreneur in Residence program where individuals work as contract employees of KYOTO-iCAP to search for and develop university-originated research seeds while preparing to found their own businesses, creating a pipeline of investment-ready companies for the firm.

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Kyoto University Hospital - Advanced Medical Research and Development OrganizationcoreStrategic or Co-development Partner · 6 January 2026Physiologas Technologies contracted with Kyoto University Hospital's Advanced Medical Research and Development Organization to support clinical development and data analysis, connecting the portfolio company with university hospital infrastructure for medical device development.
• INCJ, Ltd.minorOthersListed as a public-private fund contact point for seed-stage startup support on KYOTO-iCAP's Related Links page. INCJ (Innovation Network Corporation of Japan) is a Japanese government-backed investment fund.
• UTokyo Innovation Platform Co., Ltd.minorOthersListed as a public-private fund contact point for seed-stage startup support on KYOTO-iCAP's Related Links page. Related university-launched VC in the Japanese ecosystem.
• Osaka University Venture Capital Co., Ltd.minorOthersListed as a public-private fund contact point for seed-stage startup support on KYOTO-iCAP's Related Links page. Related university-launched VC in the Japanese ecosystem.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Global Brain Corporation: Large Japanese venture capital firm with deep-tech and university-startup investment focus and international presence, comparable as an established Japanese VC competing for similar deal flow in the deep-tech space.
• JAFCO Group Co., Ltd. One of Japan's largest venture capital and private equity firms with broad sector coverage, comparable as a major Japanese institutional investor operating in the same venture market though not specialized in university-originated deals.

Direct peers

• University of Tokyo Edge Capital Partners (UTEC): University of Tokyo-affiliated early-stage deep-tech VC, closely comparable to KYOTO-iCAP in focus on science and technology-based startups originating from academic research in Japan.
• Osaka University Venture Capital Co., Ltd. (OUVC): Venture capital firm established by Osaka University to commercialize its research output, serving as a directly comparable university-launched VC in the same Japanese ecosystem with similar deep-tech and life-sciences focus.
• UTokyo Innovation Platform Co., Ltd. (UTokyo IPC): Wholly-owned venture capital arm of the University of Tokyo, directly comparable to KYOTO-iCAP as a Japanese national university-launched VC investing in university-originated deep-tech startups with affiliated startup creation programs.
• Tohoku University Venture Partners (THVP): Tohoku University-affiliated venture capital firm investing in startups originating from university research, comparable to KYOTO-iCAP as a Japanese national university-launched VC with similar EIR-style entrepreneur development programs.

Others

• INCJ, Ltd. (Innovation Network Corporation of Japan): Japanese government-backed public-private investment fund; KYOTO-iCAP lists INCJ as a referral contact for seed-stage startup support, making it an adjacent ecosystem participant in the Japanese deep-tech commercialization landscape.

Emerging players

• ANRI Corporation: Japanese seed and early-stage venture capital firm focused on tech and deep-tech startups, partially comparable to KYOTO-iCAP as a Japanese VC backing science- and technology-driven founders.
• Beyond Next Ventures Inc. Japanese early-stage VC focused on university-originated and deep-tech startups with accelerator programs, comparable to KYOTO-iCAP in supporting researchers and scientists commercializing Japanese academic IP.

Regional players

• Pavilion Capital Pte. Ltd. Singapore-headquartered, Temasek-backed PEVC firm with Japan focus; Raymond Woo, KYOTO-iCAP's Singapore Office Representative, previously worked at Pavilion Capital, making it a relevant comparable for the firm's regional expansion ambitions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/kyoto_icap
• YouTubeyoutube.com/channel/UCqc5Sp453RpmBqQHnCrR-gA
• Facebookfacebook.com/KYOTOiCAP

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments116 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kyoto University Innovation Capital